Article Text

Download PDFPDF
Way-out developments at BATCO
  1. W King1,
  2. R Borland1,
  3. M Christie2
  1. 1VicHealth Centre for Tobacco Control, the Cancer Council Victoria, Victoria, Australia
  2. 2Department of Pharmacology and The Medical Foundation, University of Sydney, Sydney, New South Wales, Australia
  1. Correspondence to: Bill King, VicHealth Centre for Tobacco Control, the Cancer Council Victoria, 1 Rathdowne St, Carlton, Victoria 3053, Australia; bill.king{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Working in tobacco control, it is easy to get the impression that the tobacco industry is a united front, with all parties carefully avoiding internal divisions that might undermine the greater struggle against the “antis”. However, tobacco industry documents that have been made public as a result of litigation in the USA frequently reveal ruthless competition for market share, as well as intense suspicion about competitors’ activities. This was brought home to us recently when reading a 1977 document on “developments in the scientific field” by Dr Sydney J Green, then British American Tobacco’s (BAT’s) senior scientist for research and development.1 After several pages of unremarkable reports on industry and external research on low tar cigarettes and smoking and health, Green informed his readers about two “way-out” developments at BAT: …

View Full Text